GENE ONLINE|News &
Opinion
Blog

Ranking & Reports
9 Leading Molecular Diagnostics Companies to Watch in Taiwan
2021-11-15
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
2021-10-05
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
10 Precision Oncology Companies to Look Out for
2021-05-27
10 Top Gene Therapy Companies in 2021
2021-03-26
How Does China Tackle the Issue of Patent Protection? A Deepdive into China’s Patent Trends
2021-03-19
Mainstream Generic Drugs Become Stumbling Blocks for Drug Innovation: A Deepdive into China’s Patent Trends
2021-03-17
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
2020-China’s Biomedicine Industry Ushers New Upsurge of IPO listings
2020-12-07
Connect with the Top 50 Epidemic Prevention Companies from Taiwan
2020-11-26
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
GeneOnline’s Top Ten Headlines of the Year
2019-12-30
1 2
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!